Last Close
Jan 29  •  04:00PM ET
4.05
Dollar change
+0.04
Percentage change
1.00
%
Index- P/E- EPS (ttm)-0.36 Insider Own13.67% Shs Outstand37.82M Perf Week2.53%
Market Cap166.17M Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float35.42M Perf Month15.71%
Enterprise Value180.47M PEG- EPS next Q-0.06 Inst Own38.26% Short Float0.32% Perf Quarter30.65%
Income-14.54M P/S3.47 EPS this Y53.42% Inst Trans-0.93% Short Ratio0.94 Perf Half Y113.16%
Sales47.90M P/B26.19 EPS next Y-19.48% ROA-24.63% Short Interest0.11M Perf YTD15.71%
Book/sh0.15 P/C6.61 EPS next 5Y18.60% ROE-172.18% 52W High4.44 -8.78% Perf Year181.25%
Cash/sh0.61 P/FCF- EPS past 3/5Y-14.32% -2.68% ROIC-32.57% 52W Low0.76 436.14% Perf 3Y56.98%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-0.29% 11.24% Gross Margin33.81% Volatility6.62% 6.18% Perf 5Y-63.08%
Dividend TTM- EV/Sales3.77 EPS Y/Y TTM55.62% Oper. Margin-19.84% ATR (14)0.24 Perf 10Y84.09%
Dividend Ex-Date- Quick Ratio3.61 Sales Y/Y TTM-1.32% Profit Margin-30.35% RSI (14)57.40 Recom1.40
Dividend Gr. 3/5Y- - Current Ratio4.44 EPS Q/Q64.14% SMA206.69% Beta1.60 Target Price6.00
Payout- Debt/Eq6.70 Sales Q/Q12.10% SMA505.93% Rel Volume0.43 Prev Close4.01
Employees220 LT Debt/Eq6.63 EarningsNov 06 BMO SMA20059.10% Avg Volume119.56K Price4.05
IPOFeb 22, 1999 Option/ShortYes / Yes EPS/Sales Surpr.51.17% 7.30% Trades Volume51,702 Change1.00%
Date Action Analyst Rating Change Price Target Change
Dec-16-25Initiated Roth Capital Buy $6
Nov-14-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform
Nov-12-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform $8
Oct-17-24Initiated BTIG Research Neutral
Jul-14-23Initiated Stephens Overweight $8
May-20-22Initiated Lake Street Buy $12
Apr-02-19Reiterated Dougherty & Company Buy $12 → $9
Today 08:00AM
Jan-12-26 08:00AM
Dec-03-25 08:00AM
Nov-18-25 07:30AM
Nov-17-25 04:05PM
02:06PM Loading…
Nov-06-25 02:06PM
07:20AM
07:00AM
Oct-27-25 08:00AM
Oct-23-25 08:00AM
Oct-13-25 08:00AM
Sep-29-25 08:00AM
Aug-07-25 04:23PM
04:06PM
04:05PM
04:01PM Loading…
04:01PM
Jul-30-25 04:20PM
Jul-28-25 08:00AM
Jul-24-25 04:05PM
May-30-25 09:00AM
May-13-25 11:30AM
08:00AM
May-09-25 03:08AM
May-08-25 07:11AM
07:00AM
May-07-25 11:43AM
May-01-25 09:00AM
Apr-29-25 08:00AM
Apr-24-25 08:45AM
Mar-25-25 09:00AM
03:03AM Loading…
Mar-14-25 03:03AM
Mar-13-25 11:40PM
08:15AM
07:13AM
07:00AM
Feb-27-25 08:00AM
Jan-29-25 07:22AM
Jan-13-25 08:00AM
Jan-06-25 08:00AM
Dec-10-24 10:46PM
Nov-27-24 08:00AM
Nov-12-24 04:05PM
Nov-09-24 06:00AM
Nov-08-24 08:15AM
07:15AM
07:05AM
07:00AM
Nov-07-24 07:12AM
Oct-25-24 08:00AM
Oct-15-24 01:02PM
Oct-09-24 05:58PM
Oct-03-24 12:00PM
Aug-13-24 08:10AM
Aug-08-24 10:00PM
06:30PM
05:24PM
04:10PM
04:05PM
Jul-25-24 07:30AM
Jun-26-24 07:30AM
May-13-24 11:15AM
May-09-24 11:57AM
08:20AM
07:16AM
07:05AM
07:00AM
Apr-25-24 07:30AM
Apr-11-24 07:30AM
Mar-22-24 10:42AM
Mar-21-24 10:25PM
11:53AM
08:15AM
07:11AM
07:00AM
Mar-04-24 07:30AM
Feb-21-24 07:30AM
Jan-22-24 07:30AM
Jan-08-24 07:00AM
Nov-28-23 08:30AM
Nov-10-23 02:08PM
Nov-09-23 08:12AM
07:10AM
07:01AM
07:00AM
Nov-07-23 07:30AM
Oct-26-23 09:40AM
Oct-02-23 07:30AM
Aug-15-23 06:40AM
Aug-11-23 11:33AM
Aug-10-23 05:30PM
04:13PM
04:05PM
Aug-02-23 09:58AM
Jul-06-23 08:48AM
Jun-29-23 04:05PM
Jun-20-23 09:40AM
Jun-14-23 07:30AM
May-16-23 09:40AM
May-11-23 11:42PM
07:10AM
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roman Shawn DavidChief Operating OfficerJan 27 '26Option Exercise1.8012,00021,60012,000Jan 29 05:21 PM